Novartis Europharm Limited
SpainAll drugs from this manufacturer
-
It is used to treat high blood pressure in adults whose blood pressure is already controlled with amlodipine, valsartan, and hydrochlorothiazide and who benefit from taking a single tablet containing all three substances.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 12,5 mg amlodipine besylate 10 mg -
It is used to treat high blood pressure in adults whose blood pressure is already controlled with amlodipine, valsartan, and hydrochlorothiazide, and who may benefit from a single tablet containing all three active substances.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 25 mg amlodipine besylate 10 mg -
It is used to treat high blood pressure in adults whose blood pressure is already controlled with amlodipine, valsartan, and hydrochlorothiazide and who may benefit from a single tablet containing all three substances.
Dosage form: tablets, film-coated
Active substance Dosage amlodipine besylate 13,87 mg valsartan 320 mg hydrochlorothiazide 25 mg -
It is used to treat high blood pressure in adults whose blood pressure is already controlled with amlodipine, valsartan, and hydrochlorothiazide and who may benefit from a single tablet containing all three substances.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg hydrochlorothiazide 12,5 mg amlodipine besylate 5 mg -
Exforge HCT is used to treat high blood pressure in adults whose blood pressure is already controlled with amlodipine, valsartan, and hydrochlorothiazide and who benefit from taking a single tablet containing all three substances.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 160 mg amlodipine besylate 5 mg hydrochlorothiazide 25 mg -
It is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta-thalassemia major (6 years of age or older). It is also used in other types of anemia and in children aged 2 to 5 years when other treatments are not suitable, as well as in individuals aged 10 years or older with non-transfusion-dependent thalassemia syndromes.
Dosage form: tablets, film-coated
Active substance Dosage deferasirox 360 mg -
It is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta-thalassemia major (6 years of age and older). It is also used in other types of anemias and thalassemic syndromes in children and adults when other treatments are not suitable.
Dosage form: tablets, film-coated
Active substance Dosage deferasirox 90 mg -
It is used in adults to treat paroxysmal nocturnal hemoglobinuria (PNH), a disease where the immune system damages red blood cells, and to treat complement 3 glomerulopathy (C3G), a disease that affects the kidneys.
Dosage form: capsules, hard
Active substance Dosage iptacopan hydrochloride monohydrate 225,80 mg -
It is used in children from 1 year of age to treat a type of brain tumor called glioma (low or high grade), provided the tumor has a specific mutation in the BRAF gene. It is taken in combination with another medication called trametinib.
Dosage form: tablets, dispersible
Active substance Dosage dabrafenib mesilate 11,85 mg -
It is used to treat adults with type 2 diabetes when diet and exercise are not enough to control blood sugar levels.
Dosage form: tablets
Active substance Dosage vildagliptin 50 mg -
It is used to treat adults with type 2 diabetes when diet and exercise are not sufficient to control blood sugar levels.
Dosage form: tablets
Active substance Dosage vildagliptin 50 mg -
It is used in adults and in children and adolescents (10 years and older) to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or who have a severe form of the disease. It helps reduce the number of relapses and the progression of physical disability.
Dosage form: capsules, hard
Active substance Dosage fingolimod 0,5 mg -
It is used to treat adults and children with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). In adults, it is also prescribed for myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome, chronic eosinophilic leukemia, gastrointestinal stromal tumors (GIST), and dermatofibrosarcoma protuberans (DFSP).
Dosage form: tablets, film-coated
Active substance Dosage imatinib 100 mg -
It is used to treat certain types of cancer in adults and children, such as chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), gastrointestinal stromal tumors (GIST), dermatofibrosarcoma protuberans (DFSP), among other blood diseases.
Dosage form: tablets, film-coated
Active substance Dosage imatinib 400 mg -
It is used to make breathing easier in adults with chronic obstructive pulmonary disease (COPD), helping to relax the airway muscles so that air can enter and leave more easily.
Dosage form: powder for inhalation, hard capsule
Active substance Dosage indacaterol maleate 150 µg -
It is used to help adults with chronic obstructive pulmonary disease (COPD) breathe, as it relaxes the airway muscles to facilitate the intake and release of air.
Dosage form: powder for inhalation, hard capsule
Active substance Dosage indacaterol maleate 300 µg -
It is used to treat adult patients with type 2 diabetes when the disease cannot be controlled by diet and exercise alone, or when other medications such as insulin or sulfonylureas are not sufficient.
Dosage form: tablets, film-coated
Active substance Dosage metformin hydrochloride 1000 mg vildagliptin 50 mg -
It is used to treat adult patients with type 2 diabetes when the disease cannot be controlled by diet and exercise alone, or with other medications such as insulin or sulfonylureas.
Dosage form: tablets, film-coated
Active substance Dosage metformin hydrochloride 850 mg vildagliptin 50 mg -
It is used to treat various inflammatory diseases, such as periodic fever syndromes (CAPS, TRAPS, HIDS/MKD, and familial Mediterranean fever), Still's disease (including adult-onset Still's disease and systemic juvenile idiopathic arthritis), and arthritic gout in adults.
Dosage form: solution for injection
Active substance Dosage canakinumab 150 mg -
It is used to treat adults with an enlarged spleen or symptoms related to myelofibrosis, as well as adults with polycythemia vera who do not tolerate or are resistant to hydroxyurea. It is also used to treat graft-versus-host disease (GVHD) in adults and children (28 days or older for the acute form, and 6 months or older for the chronic form).
Dosage form: tablets
Active substance Dosage ruxolitinib 10 mg -
It is used to treat adults with myelofibrosis (a type of blood cancer) who have an enlarged spleen or related symptoms. It is also used to treat polycythemia vera in adults who do not tolerate or are resistant to hydroxyurea, and to treat graft-versus-host disease (GVHD) in both adults and children (depending on age and type of GVHD).
Dosage form: tablets
Active substance Dosage ruxolitinib 15 mg -
It is used to treat adults with an enlarged spleen or symptoms related to myelofibrosis, and adults with polycythemia vera who do not tolerate or are resistant to hydroxyurea. It is also used to treat acute graft-versus-host disease (GVHD) in children aged 28 days or older and adults, and chronic GVHD in children aged 6 months or older and adults.
Dosage form: tablets
Active substance Dosage ruxolitinib 20 mg -
It is used to treat adults with myelofibrosis (a type of blood cancer) who have an enlarged spleen or related symptoms, and adults with polycythemia vera who do not tolerate or are resistant to hydroxyurea. It is also used to treat graft-versus-host disease (GVHD) in adults and children (28 days or older for the acute form, and 6 months or older for the chronic form).
Dosage form: tablets
Active substance Dosage ruxolitinib 5 mg -
It is used to treat acute graft-versus-host disease (aGVHD) in children 28 days of age or older and adults, as well as chronic graft-versus-host disease (cGVHD) in children 6 months of age or older and adults.
Dosage form: solution, oral
Active substance Dosage ruxolitinib phosphate 6,60 mg/ml -
It is used to treat adult patients with type 2 diabetes when diet and exercise are not sufficient to control blood sugar levels.
Dosage form: tablets
Active substance Dosage vildagliptin 50 mg -
It is used to treat adult patients with type 2 diabetes when diet and exercise are not sufficient to control blood sugar levels.
Dosage form: tablets
Active substance Dosage vildagliptin 50 mg -
It is used to treat adults with relapsing forms of multiple sclerosis (RMS).
Dosage form: solution for injection in pre-filled pen
Active substance Dosage ofatumumab 20 mg -
It is used to treat a type of breast cancer that is hormone receptor-positive and HER2 receptor-negative, in both early breast cancer cases and advanced or metastatic cases.
Dosage form: tablets, film-coated
Active substance Dosage ribociclib 200 mg -
It is used to treat three types of white blood cell cancer: B-cell acute lymphoblastic leukemia (in children and young adults up to 25 years of age who have not responded to other treatments), diffuse large B-cell lymphoma (in adults 18 years of age or older), and follicular lymphoma (in adults 18 years of age or older).
Dosage form: solution for injection
Active substance Dosage tisagenlecleucel 1,2 x 10e6 - 2,5 x 10e8 CELULAS -
It is used in adults with high blood cholesterol levels (primary hypercholesterolemia or mixed dyslipidemia) to help reduce LDL cholesterol, also known as "bad" cholesterol. It is used alongside a diet to reduce cholesterol and can be combined with statins or other treatments.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage inclisiran sodium 300 mg -
It is used in adults with prostate cancer to perform a medical imaging test (PET) that helps detect specific cancer cells, allowing it to be determined if the cancer has spread to the lymph nodes or other tissues, or if there is a suspicion that the cancer has returned after previous treatment.
Dosage form: radiopharmaceutical preparation kit
Active substance Dosage gozetotide 25 µg -
It is used in adults to treat various eye diseases that cause vision impairment, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and retinal vein occlusion (RVO), among others. In premature infants, it is used to treat retinopathy of prematurity (ROP).
Dosage form: solution for injection
Active substance Dosage ranibizumab 2,3 mg -
It is used in adults to treat various eye diseases that cause vision impairment, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy, macular edema (swelling of the center of the retina), and other retinal lesions.
Dosage form: solution for injection
Active substance Dosage ranibizumab 1,65 mg -
It is used to treat adults and children who have lost vision due to a hereditary retinal dystrophy caused by mutations in the RPE65 gene.
Dosage form: solution for injection, concentrate and solvent
Active substance Dosage voretigene neparvovec 5 x 10¹² vg/ml -
It is used to treat adults with secondary progressive multiple sclerosis (SPMS) who have active disease, meaning they still experience relapses or show signs of inflammation on MRI.
Dosage form: tablets, film-coated
Active substance Dosage siponimod fumaric acid 0.278 mg -
It is used to treat adults with secondary progressive multiple sclerosis (SPMS) with active disease, meaning there are still relapses or signs of inflammation on MRI.
Dosage form: tablets, film-coated
Active substance Dosage siponimod fumaric acid 1,112 mg -
It is used to treat adults with secondary progressive multiple sclerosis (SPMS) with active disease, meaning when there are still relapses or signs of inflammation on MRI.
Dosage form: tablets, film-coated
Active substance Dosage siponimod fumaric acid 2.224 mg -
It is used to treat a type of skin cancer called melanoma that has spread to other parts of the body or cannot be removed by surgery. It can also be used to prevent melanoma from reappearing after surgery. Additionally, in combination with another medication (dabrafenib), it is used to treat a type of non-small cell lung cancer (NSCLC).
Dosage form: tablets, film-coated
Active substance Dosage trametinib 0,5 mg -
It is used to treat a type of skin cancer called melanoma that has spread to other parts of the body or cannot be removed by surgery. It can also be used to prevent melanoma from coming back after surgery. Additionally, in combination with dabrafenib, it is used to treat a type of non-small cell lung cancer (NSCLC).
Dosage form: tablets, film-coated
Active substance Dosage trametinib 2 mg -
It is used to treat a type of heart failure in adults, children, and adolescents (from one year of age), which occurs when the heart is weak and cannot pump enough blood to the body.
Dosage form: tablets, film-coated
Active substance Dosage valsartan 25,7 mg sacubitril 24,3 mg -
It is used to treat a type of heart failure in adults, children, and adolescents (from one year of age), which occurs when the heart is weak and cannot pump enough blood to the body.
Dosage form: tablets, film-coated
Active substance Dosage sacubitril 48,6 mg valsartan 51,4 mg -
It is used to treat a type of heart failure in adults, children, and adolescents (from one year of age). This condition occurs when the heart is weak and cannot pump enough blood to the body.
Dosage form: tablets, film-coated
Active substance Dosage sacubitril 97,2 mg valsartan 102,8 mg -
It is used in adults to prevent and relieve pain and inflammation in the eye following cataract surgery, and to reduce the risk of swelling (macular edema) in diabetic patients after such surgery.
Dosage form: suspension, ophthalmic
Active substance Dosage nepafenac 1,0 mg -
It is used in adults to prevent and relieve pain and inflammation in the eye following cataract surgery. It also helps reduce the risk of inflammation in the back of the eye (macular edema) in diabetic patients after such surgery.
Dosage form: suspension, ophthalmic
Active substance Dosage nepafenac 3,0 mg/ml -
It is used to make breathing easier in adults with chronic obstructive pulmonary disease (COPD), as it helps relax the airway muscles so that air can enter and leave more easily.
Dosage form: powder for inhalation, hard capsule
Active substance Dosage indacaterol maleate 150 µg -
It is used to make breathing easier in adults with chronic obstructive pulmonary disease (COPD). It helps relax the muscles in the airways so that air can enter and leave the lungs more easily.
Dosage form: powder for inhalation, hard capsule
Active substance Dosage indacaterol maleate 300 µg -
It is used to treat the signs and symptoms of seasonal allergic conjunctivitis, such as itching, redness, and inflammation of the eye surface caused by allergens such as pollen, dust, or animal hair.
Dosage form: solution, ophthalmic
Active substance Dosage olopatadine hydrochloride 1 mg -
It is used to make breathing easier in adults with chronic obstructive pulmonary disease (COPD). It helps relax the muscles in the airways so that air can enter and leave the lungs more easily.
Dosage form: powder for inhalation, hard capsule
Active substance Dosage indacaterol 150 mg -
It is used to help adults with chronic obstructive pulmonary disease (COPD) breathe better. The medication relaxes the airway muscles to facilitate the intake and release of air.
Dosage form: powder for inhalation, hard capsule
Active substance Dosage indacaterol 300 mg -
It is used to treat postmenopausal men and women with a type of advanced breast cancer (hormone receptor-positive and epidermal growth factor receptor 2-negative) that has not responded to other hormonal treatments and presents mutations in the PIK3CA gene.
Dosage form: tablets, film-coated
Active substance Dosage alpelisib 150 mg